Akero Therapeutics Officer Sells Shares
| Reporter Name | Yale Catriona |
| Relationship | Chief Development Officer |
| Type | Sell |
| Amount | $651,960 |
| SEC Filing | Form 4 |
Yale Catriona, Chief Development Officer at Akero Therapeutics, sold 20,000 shares of Common Stock on October 30 and November 1, 2024, under a Rule 10b5-1 trading plan. The sales were made at weighted average prices of $32.526 and $32.619, respectively, totaling $651,960. Following these transactions, Catriona directly owns 74,158 shares of Akero Therapeutics.
SEC Filing: Akero Therapeutics, Inc. [ AKRO ] - Form 4 - Nov. 01, 2024